QST

Saudi Arabia Data Center Market Investment Analysis Report 2023-2028: Opportunities in IT, Electrical, Mechanical Infrastructure, General Construction, and Tier Standards

Retrieved on: 
화요일, 7월 4, 2023

DUBLIN, July 4, 2023 /PRNewswire/ -- The "Saudi Arabia Data Center Market - Investment Analysis & Growth Opportunities 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, July 4, 2023 /PRNewswire/ -- The "Saudi Arabia Data Center Market - Investment Analysis & Growth Opportunities 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The Saudi Arabia data center market is expected to reach a value of $2.08 billion by 2028 from $1.31 billion in 2022, growing at a CAGR of 7.98% from 2022-2028
    This report analyses the Saudi Arabia data center market share.
  • Riyadh is the primary location for investment in the Saudi Arabia data center market, followed by Jeddah, Dammam, and other cities.
  • Which all cities are included in Saudi Arabia data center market report?

Saudi Arabia Data Center Market Investment Analysis Report 2023: Market to Reach a Value of $2.08 Billion by 2028 - Lucrative Opportunities in Existing and Upcoming Facilities - ResearchAndMarkets.com

Retrieved on: 
목요일, 6월 29, 2023

The "Saudi Arabia Data Center Market - Investment Analysis & Growth Opportunities 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Saudi Arabia Data Center Market - Investment Analysis & Growth Opportunities 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The Saudi Arabia data center market is expected to reach a value of $2.08 billion by 2028 from $1.31 billion in 2022, growing at a CAGR of 7.98% from 2022-2028
    This report analyses the Saudi Arabia data center market share.
  • Riyadh is the primary location for investment in the Saudi Arabia data center market, followed by Jeddah, Dammam, and other cities.
  • Which all cities are included in Saudi Arabia data center market report?

Middle East Data Center Construction Market Outlook Report 2023: Market is Expected to Reach a Value of $2.861 Billion by 2028 from $1.845 Billion in 2022 - ResearchAndMarkets.com

Retrieved on: 
화요일, 5월 9, 2023

The "Middle East Data Center Construction Market - Industry Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Middle East Data Center Construction Market - Industry Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The presence of industrial parks, the availability of land, and the government's support motivate data center operators to develop data centers in Middle Eastern countries.
  • In the Middle East data center construction market, the presence of smart cities in the region also drives investments.
  • The surge in data center activities across the country will be a major source of revenue for construction contractors.

Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses

Retrieved on: 
화요일, 4월 18, 2023

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that the U.S. FDA has renewed its licenses to the DILIsym® software platform, the flagship quantitative systems toxicology (QST) software for predicting and investigating drug-induced liver injury (DILI).

Key Points: 
  • Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that the U.S. FDA has renewed its licenses to the DILIsym® software platform, the flagship quantitative systems toxicology (QST) software for predicting and investigating drug-induced liver injury (DILI).
  • The one-year renewal provides continued access to DILIsym software for authorized FDA employees across all FDA divisions.
  • The recent signing of the FDA Modernization Act 2.0 by President Biden, which encourages the FDA to limit animal use in drug development, should be a positive catalyst for greater utilization of DILIsym software in drug development.
  • For the past 13 years, DILIsym Services, a division of Simulations Plus, has coordinated the DILI-sim Initiative, which is a public-private partnership that has guided development of the DILIsym software package.

Middle East Data Center Construction Market Report 2023: Rising Adoption of Renewable Energy Sources Bolsters Sector

Retrieved on: 
화요일, 4월 18, 2023

DUBLIN, April 17, 2023 /PRNewswire/ -- The "Middle East Data Center Construction Market - Industry Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, April 17, 2023 /PRNewswire/ -- The "Middle East Data Center Construction Market - Industry Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The Middle East data center construction market is expected to growi at a CAGR of 7.59% during 2022 to 2028.
  • Digitalization across businesses will increase data center investments by colocation, cloud, Internet, and telecommunication providers.
  • The presence of industrial parks, the availability of land, and the government's support motivate data center operators to develop data centers in Middle Eastern countries.

The Canadian Vaping Association cautions the Government of Quebec on its proposed vape tax

Retrieved on: 
금요일, 2월 10, 2023

Vaping being more affordable than smoking was previously among the incentives for smokers to switch to a less harmful product.

Key Points: 
  • Vaping being more affordable than smoking was previously among the incentives for smokers to switch to a less harmful product.
  • This tax eliminates that incentive and punishes people who smoke for trying to end their addiction to combustible tobacco and improve their health.
  • The excise tax prioritizes short-term financial gains over longer-term improvements to public health and reductions in health care costs.
  • The Canadian Vaping Association implores the Government of Quebec to reconsider a provincial vape tax.

North America Silicon EPI Wafer Market Report 2023: Sector to Reach $1.17 Billion by 2028 with an 8.5% CAGR

Retrieved on: 
목요일, 1월 19, 2023

An epitaxial wafer, also known as an EPI wafer, is created by placing a layer of epitaxial silicon single crystal on a single crystal silicon wafer.

Key Points: 
  • An epitaxial wafer, also known as an EPI wafer, is created by placing a layer of epitaxial silicon single crystal on a single crystal silicon wafer.
  • This is likely to drive the North America silicon EPI wafer market at a notable CAGR during the forecast period.
  • The North America silicon EPI wafer market is segmented on the basis of wafer size, application, end user, type, and country.
  • Based on country, the North America silicon EPI wafer market is segmented into the US, Mexico, and Canada.

North America Silicon EPI Wafer Market Report 2023: Rising Demand for Epitaxial Wafers in Consumer Electronics Bolsters Growth - ResearchAndMarkets.com

Retrieved on: 
목요일, 1월 12, 2023

An epitaxial wafer, also known as an EPI wafer, is created by placing a layer of epitaxial silicon single crystal on a single crystal silicon wafer.

Key Points: 
  • An epitaxial wafer, also known as an EPI wafer, is created by placing a layer of epitaxial silicon single crystal on a single crystal silicon wafer.
  • The North America silicon EPI wafer market is segmented on the basis of wafer size, application, end user, type, and country.
  • By end user, the North America silicon EPI wafer market is segmented into consumer electronics, automotive, healthcare, aerospace and defense, and others.
  • Based on country, the North America silicon EPI wafer market is segmented into the US, Mexico, and Canada.

Simulations Plus Releases DILIsym X (DSX) Beta with Redesigned Software Infrastructure

Retrieved on: 
목요일, 1월 12, 2023

Simulations Plus , Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its DILIsym Services (DSS) division has released DILIsym® version X (DSX) Beta, the latest version of its flagship quantitative systems toxicology (QST) software for predicting and investigating drug-induced liver injury (DILI).

Key Points: 
  • Simulations Plus , Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its DILIsym Services (DSS) division has released DILIsym® version X (DSX) Beta, the latest version of its flagship quantitative systems toxicology (QST) software for predicting and investigating drug-induced liver injury (DILI).
  • DSX represents a great advance in that it simplifies the use of the software and greatly increases the speed with which it provides results.
  • This will enable much wider adoption of the software by Pharma, regulators, and academics.”
    Dr. Brett Howell , president of the DILIsym Services division, added: “DILIsym is increasingly being used for high impact applications in the safety space.
  • For the past 12 years, the DILIsym Services division has coordinated the DILI-sim Initiative, which is a public-private partnership that has guided development of the DILIsym software package.

JOGO Health to Present Positive Clinical Data for Treating Non-Specific Low Back Pain With Digital Therapeutics at World Congress on Pain

Retrieved on: 
목요일, 9월 15, 2022

Non-specific low back pain is one of the most common reasons Americans miss work or leave jobs entirely.

Key Points: 
  • Non-specific low back pain is one of the most common reasons Americans miss work or leave jobs entirely.
  • A professional organization estimates 200 million US productivity hours are consequently lost every year and nearly 40 million workers suffer from non-specific low back pain.
  • "Compared to baseline waitlist comparison groups, the JOGO-Gx group demonstrated statistically significant changes in pain intensity, pain interference and low back pain reduction.
  • Although we didn't conduct a head-to-head study, data show JOGO-Gx could be superior to opioids in treating chronic lower back pain."